1. Home
  2. TWST vs CHE Comparison

TWST vs CHE Comparison

Compare TWST & CHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

HOLD

Current Price

$91.19

Market Cap

5.2B

Sector

Health Care

ML Signal

HOLD

CHE

Chemed Corp

HOLD

Current Price

$507.57

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWST
CHE
Founded
2013
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Nursing Services
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
6.1B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
TWST
CHE
Price
$91.19
$507.57
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$46.88
$501.50
AVG Volume (30 Days)
1.5M
145.5K
Earning Date
05-04-2026
04-23-2026
Dividend Yield
N/A
0.57%
EPS Growth
63.89
N/A
EPS
N/A
4.84
Revenue
$376,572,000.00
$2,529,978,000.00
Revenue This Year
$18.91
$6.56
Revenue Next Year
$15.07
$6.23
P/E Ratio
N/A
$103.93
Revenue Growth
20.32
4.06
52 Week Low
$23.30
$365.21
52 Week High
$105.47
$517.74

Technical Indicators

Market Signals
Indicator
TWST
CHE
Relative Strength Index (RSI) 52.65 70.28
Support Level $86.30 $417.56
Resistance Level $105.47 N/A
Average True Range (ATR) 6.31 12.05
MACD -1.21 -0.02
Stochastic Oscillator 38.28 82.48

Price Performance

Historical Comparison
TWST
CHE

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

About CHE Chemed Corp

Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Share on Social Networks: